Clinical trials
Active, not recruiting Phase 2 trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 14 |
| 2024 | 25 |
| 2025 | 22 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 86 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 9 |
| Merck Sharp & Dohme LLC | 8 |
| Novartis Pharmaceuticals | 8 |
| GlaxoSmithKline | 6 |
| Eli Lilly and Company | 5 |
| Hoffmann-La Roche | 5 |
| AstraZeneca | 3 |
| Immunovant Sciences GmbH | 3 |
| Janssen Research & Development, LLC | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 8 |
| Breast Neoplasms | 6 |
| Colitis, Ulcerative | 6 |
| Autoimmune Diseases | 5 |
| Asthma | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Idiopathic Pulmonary Fibrosis | 4 |
| Immune System Diseases | 4 |
| Lung Diseases, Interstitial | 4 |
| Scleroderma, Diffuse | 4 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.